Melissa Tosca - 21 Oct 2022 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role: EVP of Finance
Signature: /s/ Melissa Tosca
Issuer symbol: KPRX
Transactions as of: 21 Oct 2022
Net transactions value: $0
Form type: 4
Filing time: 25 Oct 2022, 17:32:33 UTC
Previous filing: 22 Sep 2022
Next filing: 07 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KPRX	Common Stock	Award	$0	+2,500		$0.000000	2,500	21 Oct 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KPRX	Stock Option (right to buy)	Award	$0	+5,000		$0.000000	5,000	21 Oct 2022	Common Stock	5,000	$6.78	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date.
F2	The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.

Content

Grant of restricted stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan (the "Plan"). The restrictions will vest as to one-third (1/3) of the shares on each of September 13, 2023, September 13, 2024 and September 13, 2025, subject to the reporting person's continuous service through each such vesting date.

The reporting person received an option to purchase Common Stock from the Issuer pursuant to the Plan. The option will become exercisable as to one-third (1/3) of the shares underlying the Option on September 13, 2023, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years, subject to the reporting person's continuous service through each such vesting date.